| Literature DB >> 34947943 |
Katsuhiko Kadota1, Keiichi Onoda2, Satoshi Abe1, Chizuko Hamada1, Shingo Mitaki1, Hiroaki Oguro1, Atsushi Nagai1, Hajime Kitagaki3, Shuhei Yamaguchi1.
Abstract
Distinguishing progressive supranuclear palsy (PSP) from multiple system atrophy (MSA) in the early clinical stages is challenging; few sensitive and specific biomarkers are available for their differential diagnosis. Resting-state functional magnetic resonance imaging (rs-fMRI) is used to study the fluctuations in blood oxygen level-dependent (BOLD) signals at rest, which provides evidence for aberrant brain functional networks in neurodegenerative diseases. We aimed to examine whether rs-fMRI data could differentiate between PSP and MSA via a multiscale entropy (MSE) analysis of BOLD signals, which estimates the complexity of temporal fluctuations in brain activity. We recruited 14 and 18 patients with PSP and MSA, respectively, who underwent neuropsychological tests and rs-fMRI. PSP patients demonstrated greater cognitive function impairments, particularly in the frontal executive function. The bilateral prefrontal cortex revealed lower entropy BOLD signal values in multiple time scales for PSP, compared to the values observed in MSA patients; however, the functional connectivity of the representative brain networks was comparable between the diseases. The reduced complexity of BOLD signals in the prefrontal cortex was associated with frontal dysfunction. Thus, an MSE analysis of rs-fMRI could differentiate between PSP and MSA, and the reduced complexity of BOLD signals could be associated with cognitive impairment.Entities:
Keywords: connectivity; frontal executive function; multiscale entropy; multisystem; neural network; progressive supranuclear palsy; resting-state functional MRI; rs-fMRI
Year: 2021 PMID: 34947943 PMCID: PMC8707613 DOI: 10.3390/life11121411
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
Background characteristics of the patients.
| PSP | MSA | ||
|---|---|---|---|
| N | 14 | 18 | |
| Age (years) | 73.5 ± 6.2 | 69.3 ± 8.7 | 0.132 |
| Sex (female/male) | 9/5 | 10/8 | 0.618 |
| Disease duration (years) | 3.3 ± 1.7 | 5.1 ± 3.2 | 0.073 |
| mRS | 3.2 ± 0.8 | 3.5 ± 0.8 | 0.750 |
| MMSE | 22.8 ± 4.6 | 25.8 ± 3.7 | 0.051 |
| FAB | 9.1 ± 3.4 | 13.2 ± 3.6 | 0.004 |
| SDS | 45.1 ± 10.4 | 39.5 ± 11.4 | 0.161 |
| AS | 17.6 ± 6.7 | 14.8 ± 8.2 | 0.317 |
| SBI (%) | 14.3 | 11.1 | 0.425 |
| CMB (%) | 7.1 | 11.1 | 0.702 |
| PVH (0/1/2, %) | 12.5/42.9/28.6 | 33.3/38.9/27.8 | 0.956 |
| DSWMH (0/1/2/3, %) | 21.4/35.7/28.6/14.3 | 27.8/22.2/33.6/16.7 | 0.868 |
| Head movement (mm) | 0.77 ± 0.57 | 0.69 ± 0.58 | 0.715 |
Numerical data are shown as mean ± standard deviation. The t-test is used for the numerical data, including age, disease duration, neuropsychological scores, and head movement during resting-state fMRI. The χ2 test is used to assess the sex and brain indices. mRS, modified Rankin scale; MMSE, Mini-Mental State Examination; FAB, Frontal Assessment Battery; SDS, Self-rating Depression Scale; AS, Apathy Scale; SBI, silent brain infraction; CMB, cerebral microbleeds; PVH, periventricular hyperintensity; DSWMH, deep and subcortical white matter hyperintensity.
Figure 1(A) Applying the coarse-graining process to a time series. For a certain time series, multiple coarse-grained time series are constructed by averaging the data in non-overlapping windows of progressively increasing length. (B) To illustrate the procedure for calculating the sample entropy, a time series (u) is displayed. The length of the pattern (m) is set to 2, and the criterion of similarity (r) is specified as 0.3 of the standard deviation of u. The dotted horizontal lines surrounding u1, u2, and u3 indicate u1 ± r, u2 ± r, and u3 ± r, respectively. Two data values are comparable, and if the absolute difference is
Figure 2Functional connectivity between 90 regions of the automated anatomical labelling (AAL) in progressive supranuclear palsy (PSP) and multiple system atrophy (MSA). Red and blue denote positive and negative connectivity, respectively.
Figure 3Columns 1 and 2 present the average maps of the sample entropy (lateral and medial views) for scales 1–4 for progressive supranuclear palsy (PSP; first column) and multiple system atrophy (MSA; second column). Columns 3 and 4 represent the group comparisons of sample entropy using entire-brain t-test (false discovery rate-corrected p < 0.05 at the cluster level and uncorrected p < 0.001 at the voxel level).
Brain regions displaying decreased entropy in PSP compared to MSA.
| Scale 2 | Scale 3 | Scale 4 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| [x, y, z] | Size | pFDR | [x, y, z] | Size | pFDR | [x, y, z] | size |
| |
| Left PFC | - | - | - | [−26, 36, 9] | 223 | 0.041 | - | - | - |
| Right PFC | [33, 27, 9] | 486 | 0.005 | [39, 36, 3] | 828 | <0.001 | [39, 36, 6] | 364 | <0.001 |
PSP, progressive supranuclear palsy; MSA, multiple system atrophy; PFC, prefrontal cortex; FDR, false discovery rate [x, y, z] indicates the Montreal Neurological Institute (MNI) coordinates.
Correlation between the multiscale entropy and neuropsychological scores.
| MMSE | FAB | SDS | AS | ||
|---|---|---|---|---|---|
| Scale 2 | PFC (R) | 0.142 | 0.416 | 0.026 | −0.095 |
| Scale 3 | PFC (L) | 0.492 * | 0.553 * | 0.004 | −0.084 |
| PFC (R) | 0.181 | 0.393 | −0.112 | −0.066 | |
| Scale 4 | PFC (R) | 0.353 | 0.572 * | −0.078 | −0.092 |
* false discovery rate (FDR)-corrected p < 0.05 (uncorrected p < 0.004). MMSE, Mini-Mental State Examination; FAB, Frontal Assessment Battery; SDS, Self-rating Depression Scale; AS, apathy scale; PFC, prefrontal cortex.
Figure 4Correlations between multi scale entropy and neuropsychological scores. PFC, prefrontal cortex; MMSE, mini-mental examination; FAB, frontal assessment battery. Each point represents an individual patient with progressive supranuclear palsy (PSP, red) or multiple system atrophy (MSA, blue).